Unaltered Metabolism of Phenytoin in Thyroid Disorders
- 13 March 2009
- journal article
- research article
- Published by Wiley in Acta Pharmacologica et Toxicologica
- Vol. 42 (5) , 343-346
- https://doi.org/10.1111/j.1600-0773.1978.tb02214.x
Abstract
The metabolism of phenytoin was studied in 9 hyperthyroid and 7 hypothyroid patients before and after treatment with either antithyroid drugs or l-thyroxine. No difference in the half-life, volume of distribution and metabolic clearance rate was found between untreated hyper- and hypothyroid subjects. Normalization of thyroid function test did not change the kinetic parameters of phenytoin. The well-known correlation between thyroid function and antipyrine kinetics evidently cannot be extrapolated uncritically to other drugs. No general rules are valid in the kinetics among different drugs in thyroid pathological conditions. Each drug must be evaluated by itself in different pathological conditions.Keywords
This publication has 17 references indexed in Scilit:
- Plasma protein binding of drugs in thyroid dysfunction [proceedings]Published by Wiley ,1977
- Studies of the effect of thyroid dysfunction on the elimination of beta‐ adrenoreceptor blocking drugs.British Journal of Clinical Pharmacology, 1977
- The Kinetics of Propylthiouracil in HyperthyroidismActa Pharmacologica et Toxicologica, 1975
- Sulfamethizole‐induced inhibition of diphenylhydantoin, tolbutamide, and warfarin metabolismClinical Pharmacology & Therapeutics, 1975
- Altered plasma half‐lives of antipyrine, propylthiouracil, and methimazole in thyroid dysfunctionClinical Pharmacology & Therapeutics, 1975
- Effects of Hypothyroidism and Hyperthyroidism on Dipyrone Metabolism in ManThe Journal of Clinical Pharmacology, 1974
- Comparative drug elimination capacity in man‐glutethimide, amobarbital, antipyrine, and sulfinpyrazoneClinical Pharmacology & Therapeutics, 1973
- Norphenazone, a new metabolite of phenazone in human urineJournal of Pharmacy and Pharmacology, 1973
- Change in receptor site affinity: A proposed explanation for the potentiating effect of D‐thyroxine on the anticoagulant response to warfarinClinical Pharmacology & Therapeutics, 1967
- II. The effect of D‐thyroxine, clofibrate, and norethandroloneClinical Pharmacology & Therapeutics, 1967